Welcome to Our Medtech Talk Podcast Channel

Too often we define the Medtech sector by the number of dollars raised, IPOs helped or companies sold. But the focus neglects the very foundation of the sector - the People. Join the Medtech Talk Podcast each week to hear from entrepreneurs, investors and executives who spend their days developing the tools that make sick people well and health care more efficient.

Windham’s Yee on Why She Thinks Medtech’s Renaissance is Drawing Future New Leaders

April 14, 2016

Cynthia Yee, a principal at Windham Venture Partners, opened her firm’s office in San Francisco. Yee shares her opinions on many medtech questions including 510(k) versus PMA, the power of payers, and how younger professionals view careers in medtech.

Cynthia Yee

Principal

Windham Venture Partners

Cynthia Yee is a Principal at Windham Venture Partners and is a Board Director at ClarVista Medical and NeuSpera Medical and a Board Observer at Cartiva, Personal Genome Diagnostics (PGDx) and VytronUS. She has diverse experience investing in public and private healthcare companies across the medical device and healthcare IT sectors. Prior to joining Windham, Cynthia served as Director of Business Development & Strategic Marketing at Advanced Cardiac Therapeutics (ACT), a venture-backed medical device start-up. Previously, she was an Associate on the Healthcare team at New Enterprise Associates (NEA) and focused on investments in medical device, biopharmaceutical and healthcare services companies. Cynthia began her career in equity research, covering medical devices at Piper Jaffray and biotechnology at Pacific Growth Equities. Cynthia graduated from the University of California, Berkeley, where she earned a BA in Integrative Biology and a BS in Business Administration from the Haas School of Business.